Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Oct 21, 2020 10:25 AM - Oct 22, 2020 4:15 PM

(US Eastern Standard Time)

Fort Washington, PA 19034

Canadian Pharmacovigilance and Risk Management Conference

Session 2: Round Table with Inspector

Session Chair(s)

Rita  Cassola, RPh

Rita Cassola, RPh

Executive Director PV

Certus PV Services Inc, Canada

In this session, a representative from the Good Pharmacovigilance Practices (GVP) Inspection Program of Health Canada will discuss updates of the Program. The session will discuss:

  • Inspection trends observed during fiscal year 2019-2020
  • The addition of market authorization holders located outside of Canada within the scope of the Program
  • The impact of COVID-19 on GVP inspections and other upcoming elements of the GVP Program Review
  • Other on-going initiatives within the Program

Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand the recent updates to the GVP Inspection Program in Canada
  • Identify what inspection findings were found in recent Health Canada GVP inspections
  • Understand what is expected during Health Canada GVP inspections

Speaker(s)

Marc-André  Giguère

Updates on the Good Pharmacovigilance Practices (GVP) Inspection Program

Marc-André Giguère

Health Canada, Canada

Senior Policy Analyst

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.